Apertura

Apertura Gene Therapy

New York, United States · Founded 2021 · $67.0M raised

Headquarters
New York, New York
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$67.0M
Last Round
$67.0M Series AApr 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Apertura Gene Therapy is widening the aperture of gene therapy opportunities for treating debilitating diseases by engineering AAV capsid and payloads to overcome current limitations in gene therapy. The company is engineering next-generation gene therapies to treat unaddressed genetic diseases using its machine learning-powered delivery and expression platforms. Apertura was founded on innovative technologies from the Broad Institute and Harvard University, with support from Deerfield Management Company, and is headquartered at the Cure. building, Deerfield's innovation campus in New York City.

Summary

Apertura is a Biotech company based in New York, United States, founded in 2021. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in Apr 2022. Investors include Deerfield Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2022
$67.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Apertura on Indexed.vc
<a href="https://indexed.vc/companies/apertura"><img src="https://indexed.vc/api/badge/company/apertura" alt="Apertura on Indexed.vc" width="260" height="76" /></a>